Financials

  • Market Capitalization 41.26 M
  • Employee 20
  • Founded 1971
  • CEO N/A
  • Website www.verupharma.com
  • Headquarter Wisconsin, United States
  • FIGI BBG000G12J78
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.45
Rapporto prezzo/fatturato
12.31

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4227
HOWL
Werewolf Therapeutics, Inc. - Common Stock
0.91 USD-1.09%+2.25%-5.21%-49.72%44.23 M USD
4239
GRCE
Grace Therapeutics, Inc. - Common Stock
2.04 USD-2.86%0.00%-8.93%-48.74%42.91 M USD
4258
LNAI
Lunai Bioworks Inc. - Common Stock
1.12 USD+2.75%-23.29%-56.42%-8.20%40.62 M USD
4285
MGX
Metagenomi Therapeutics, Inc. - Common Stock
0.99 USD+1.02%-9.17%-13.91%-31.25%37.40 M USD

Notizie